Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1

doi:10.3748/wjg.v24.i5.573

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8072)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

458

WORD

231

HTML

4391

Figures (1-6)

224

Tables (1-3)

198

Sum=5502

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1071

Download

1499

Sum=2570

Feb 7, 2018 (publication date) through Jul 30, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 7, 2018; 24(5): 573-582
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.573

Table 2 Group design

Control	DUSP1 3’-UTR	Non-targeting control
WT	DUSP1 3’-UTR	miR-202-3p
MUTA	DUSP1 3’-UTR-muta	miR-202-3p

Citation: Dou D, Shi YF, Liu Q, Luo J, Liu JX, Liu M, Liu YY, Li YL, Qiu XD, Tan HY. Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1. World J Gastroenterol 2018; 24(5): 573-582
URL: https://www.wjgnet.com/1007-9327/full/v24/i5/573.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i5.573